Radix Paeoniae Alba (RPA) is widely used in clinical treatment for gynecological diseases, particularly abnormal menstruation, menstrual pain, and breast tenderness; however, no scientific evidence base links RPA to estrogen replacement therapy. In this study, we characterize estrogenic activity of RPA using immature and ovariecto- 
regarding TM as new phytoestrogens resource. Radix Paeoniae Alba (RPA) is a traditional medicine that has been used for over 2,000 years in oriental countries because of its functions of nourishing blood, protecting liver, and alleviating pain. RPA has been widely used in clinical practice for the prevention of cardiac diseases, arthritis, and other inflammation-related disorders based on its pharmacological effects in multiple tissues (Huang, Lin, Lee, et al., 2011; Su-Hong et al., 2015; Yang et al., 2011; Zheng, Wei, Zhu, & Liu, 2007) , particularly in gynecological diseases, such as abnormal menstruation, menstrual pain, and breast tenderness (Yu, 1990) . The herb of RPA was recorded in over 50% prescriptions in Fu Qingzhu Nuke, a famous female medical book.
It was reported that RPA could increase the immature mice's uterus weight and RPA pharmacological serum-induced ER positive cell MCF-7 cell proliferation, which indicates that RPA is involve in estrogenic activity (Hao et al., 2009 ). However, despite RPA being extensively used for the treatment of gynecological diseases, no conclusive scientific data has shown that RPA is efficient in estrogen replacement therapy in contrast to isoflavones found in soybeans.
Whether RPA, as has been reported for phytoestrogens, causes few side effects or whether they are endocrine disruptors that impair uterus health. It is clear that the efficacy and molecular mechanisms of RPA need to be elucidated for this promising therapy. In the present study, in vivo models of immature and ovariectomized (OVX) mice along with in vitro studies were used to investigate its mechanism via estrogen receptor (ER) pathway. Besides, ER antagonist ICI 182,780 was studied and is part of an ongoing effort to provide scientific data and identify potent estrogen-like activity of RPA.
| MATERIALS AND METHODS

| Herbal preparation and analysis
RPA was purchased from Beijing Huamiao Medicinal Herbs CO. Ltd.
(Beijing, China). Preparation of water extract of RPA is as follows:
16.8-g RPA add 10 times distilled water, soak 30 min, decocted twice, each time for 60 min and filtered, then combine the filtrate and concentrate at 60°C rotary steam evaporator to the desired concentration of 0.1 g/ml. A high-performance liquid chromatography method was developed for the representative chemical compositions of catechinic (0.009%), peony lactone glycosides (0.584%), and paeoniflorin (0.228%). OVX mice model: 4-week-old KM mouse's dorsal ovariectomy was performed under general anesthesia using 0.3 mg/kg of chloral hydrate. In sham-operated controls, fat near the ovary was removed.
| Animals and treatment
The mice were randomly assigned to eight groups: ovariectomized without treatment (OVX) and sham operated (sham) and the rest of the groups were the same with the immature mice model. Sham and OVX group distilled water only, the rest of the group were oral administrated once a day for consecutive 7 days and 4 weeks respectively. Dose calculations followed guidelines correlating the dose equivalents between humans and laboratory animals on the basis of ratios of body surface area.
| Analysis of vaginal cornification, serum sex hormones, and target tissues
Immature and OVX mice were monitored by daily vaginal epithelium cells smear testing during the administration period. The vaginal lavage was fixed with 95% ethanol and stained with methylene blue for 10 min. Keratinized vaginal cells were observed by microscopy as being indicative of estrus (Xu, 1991) . Blood was collected by removing the eyeball for analysis of estradiol (E 2 ), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels by enzyme-linked immunosorbent assay (Beijing Xinfangcheng Biotechnology, China). The sensitivities of the three enzyme-linked immunosorbent assays were 1.0 pg/ml, 1.0 mIU/ml, and 1.0 ng/ml, respectively, and without other cross-reaction (Xu, Ding, et al., 2014a; Xu, Ma, et al., 2014b) . The uterus and vagina of immature mice and OVX mice were removed and weighed. The left horns of the uterus and the upper portion of the vagina were used for western blot and real-time quantitative polymerase chain reaction (PCR) analysis. The right horns of the uterus and the rest of the vagina were fixed with 4% polyoxymethylene for 24 hr for staining with hematoxylin and eosin for microscopy and immunohistochemistry (Xue et al., 2012) .
| Immunohistochemistry
The routine immunohistochemistry method and protocol was carried out as described (Xu, Ding, et al., 2014a; Xu, Ma, et al., 2014b) . The primary rabbit anti-ER-α antibody Antibodies( Santa Cruz Biotechnology) were diluted 1:20 and a rabbit anti-ER-β ( Santa Cruz Biotechnology) were diluted 1:30 in 5% nonfat milk and 0.1% Tween 20 in TBS.
The Image-Pro Plus 6.0 System image analysis system was used for quantitative analysis.
| Western blot
The protein was obtained in lysis buffer (50-mM Tris, pH 8.0, 5-mM EDTA, 150-mM NaCl, 0.1% sodium dodecyl sulfate, 0.5% NP-40) containing 10-mM phenylmethylsufonyl fluoride and 2-mg/ml aprotinin to detect the levels of ERα and ERβ in target tissue by western blot.
The western bolt protocol and semiquantitative analysis were carried out as described (Xu, Zhang, Geng, et al., 2010) . The antibody of rabbit anti-ERα polyclonal antibody (dilution 1/200, Santa Cruz Biotechnology) and mouse anti-ERβ monoclonal antibody (dilution 1/1000, Abcam Biotechnology) were used. Glyceraldehyde 3-phosphate dehydrogenase (dilution 1/1,000, Cell Signaling Technology) was calculated from the band density. All experiments were done in triplicate. The relative quantity of each antibody was measured by Alpha Ease FC (Fluorchem FC 2 ) software. The density ratio of protein to glyceraldehyde 3-phosphate dehydrogenase was calculated from the band density.
| Real-time quantitative PCR
According to the manufacturer's instructions, the total RNA of uterus and vagina was extracted with TRIzol reagent (Invitrogen, Carlsbad, California) and was reverse transcribed to cDNA using the HighCapacity cDNA Reverse Transcription Kit (Applied Biosystems Foster City, California). The QuantiTect SYBR Green PCR Kit (QIAGEN K.K., Tokyo, Japan) was used for the specific transcripts quantified by quantitative real-time PCR and analyzed with an ABI 7500 real-time PCR system (Applied Biosystems, Foster City, California). Gene-specific primers were used for ERα (forward: CGCCTTCTACAGGTCTAAT; reverse: GGTTCTTGTCAATGGTGC), ERβ (forward: C TGTGAGGTA GGAATGCGAAAC; reverse: GGTCTGGGTGATTGCGAAGA), and β-actin (forward: CCTCTATGCCAACA CAGTGC; reverse: CTGTAG AACGGTGT GGTCATC). The mRNA levels of ERs were normalized to the β-actin mRNA level. PCR was performed as 95°C for 10 min, followed by 40 cycles of 95°C for 30 s and 60°C for 1 min. The quantification data was analyzed with ABI Prism analysis software, and the relative mRNA expression was calculated with the comparative Ct method (Xu et al., 2014) . of the average response of the DMSO control samples (Xu et al., 2015) .
MCF-7 cells (2.0 × 10 5 cells/well) were plated in 6-well plates and preprocessing as described above. were added to three replicate wells and was incubated for 24 hr.
The formation of functional ERα/β-ERE complexes luciferase activity was evaluated by the luciferase reporter assay system from Promega (Wisconsin). Activity of the luciferase reporter gene was expressed relative to the DMSO control (Xu et al., 2015) . PerkinElmer). The data were shown by normalizing the signal of fluorescein to that of terbium (Xu, Chen, Li, et al., 2017) .
| ERα/β competitive ligand-binding assay
| Statistics analysis
The SPSS software version 11.0 for Windows (SPSS Inc, Chicago, Illinois) used for statistical analysis. All data were expressed as mean ± standard deviation and were analyzed by one-way analysis of variance followed by least significant difference or Dunnett T 3 test. Differences were considered statistically significant when P was less than 0.05.
3 | RESULTS
| Effect of RPA on the estrus cycle
To characterize the estrogenic activity of RPA, we treated immature/ OVX mice with RPA and compared the activity with the synthetic estrogen, estradiol, and combine with the ER antagonist ICI 182,780
for elucidating the ER mechanism.
The estrous cycle results are shown in Figure 1a 3.2 | Effect of RPA on rectal temperature, body, uterine, and adrenal gland weight As shown in Figure 2e , the mean adrenal gland weight of OVX Figure 3a ,b.
3.4 | Effect of RPA on histomorphology of uterus and vagina 
| Effect of RPA on activity of ERα and ERβ transcriptional activity
The formation of functional hERα/β-ERE complexes in response to treatment with the RPA was measured by HEK-293 cells stably transfected with the hERα/β-ERE-luciferase plasmid; 0.0001-0.1-mg/ml RPA and 0.001-μM 17β-estradiol both induced ERα and ERβ-ERE luciferase activity (Figure 8a,b) . RPA at 0.1 mg/ml induced a 1.21-fold up-regulation in ERα and a 1.27-fold up-regulation in ERβ luciferase activity. These effects were inhibited by ICI 182,780, resulting in 70% and 59% inhibition of ERα and ERβ-ERE-luciferase expression in cells treated with 0.1-mg/ml RPA, respectively. These data indicate that RPA clearly has estrogenic activity that is mediated through the activation of ERs. Moreover, Figure 8c ,d showed that RPA at doses 0.01-0.1 mg/ml significantly increased ERα-ERE luciferase activity and decreased ERβ-ERE luciferase activity induced by 17β-estradiol.
| Effect of RPA competing with ERs combining ability
The estrogenic activities of RPA were significantly inhibited by the specific ER antagonist ICI 182,780 in vivo and in vitro. We next examined if RPA could directly bind to ER using a TR-FRET ER competitive assay. As shown in Figure 9 , RPA at the dose range of 0.013-10 μg/ml could bind to human ERα and ERβ LBD in the dose range of 0.004-10 μg/ml, and as the concentration increased, the combination was enhanced.
| DISCUSSION
This study aimed to investigate the estrogenic effects on immature and OVX mice and molecular mechanism of its effect via the ER pathway. The results show that RPA has a potent estrogenic activity, as indicated by promoting development of uterus and vagina in immature We found that treatment with RPA promoted E 2 release and diminished the ascending FSH and LH levels in OVX mice, suggesting either the long-loop effect of RPA directly on the hypothalamus or the shortloop effect on the pituitary gland. In the absence of estrogens or under conditions of blocked ERs, the release of these excitatory and inhibitory neurotransmitters is exaggerated, and therefore, neurotransmitters spill over to the thermoregulatory hypothalamic neurons, resulting in hot flushes. This is why serum LH pulses and hot flushes occur often synchronously (Tataryn, Meldrum, Lu, Frumar, & Judd, 1979) . Recently, others have demonstrated that OVX animals have also hot flushes (Berendsen & Kloosterboer, 2003; Pan, Anthony, Binns, & Clarkson, 2001; Puri, Wuttke, & Seidlovawuttke, 2011) , which occur as frequently as the LH pulses, and these pulses of increased skin temperature are not seen in intact animals. Similarly, the lack of estrogens in OVX animals results in high pulsatile LH release and rectal temperature that can be profoundly.
In the uterus, E 2 stimulates endometrial proliferation without the addition of progestin, and this stimulation results in endometrial hyperplasia and could lead to neoplasia (Albertazzi & Sharma, 2009 ).
The vagina is another target for E 2 , because its epithelium is induced to undergo proliferation and cornification, which are the desired estrogenic effects because Lactobacillus use these cells to produce lactic acid to keep the vaginal milieu (Hertrampf et al., 2006 Under physiological conditions, the biological effects of estrogen depend not only on the level of estrogen but also on the distribution and expression levels of the corresponding ERs, ERα and ERβ, in the target cell (Pelletier, Labrie, & Labrie, 2000; Shughrue, Lane, Scrimo, & Merchenthaler, 1998) . Estrogen and ERs are involved in the physiological function regulation of the female system. A reproductive hormone plays a vital role in body weight control (Dubuc, 1985) .
Consistently, reports showed OVX rats that were deficient for estrogen and developed obesity that could be reversed by E 2 replacement therapy, which decreased food intake and increased energy expenditure (Gao et al., 2007) . Importantly, experimental data have provided evidence that estrogen signaling modulates fat accumulation and body weight by binding to ERα in vivo and in vitro (Banno, Zimmer, De Jonghe, et al., 2010; Heine, Taylor, Iwamoto, Lubahn, & Cooke, 2000; Ohlsson et al., 2000) Our results indicated that RPA as a phytoestrogen also profoundly inhibited body weight increase in OVX mice and up-regulated the expression of ERα in the target tissue of OVX mice.
Estrogen mediates its actions by binding to the ER and inducing a major conformational change, which allows the estrogen-ER complex relocate to the nucleus to bind to its cognate DNA response element (ERE) located in the promoter/enhancer regions of target genes and regulation gene transcription (Shao, Keeton, McDonnell, & Brown, 2004) . In this study, we used a TR-FRET ER competitive assay illustrating that RPA could bind to human ERα and ERβ LBD in the dose range of 0.013-10 μg/ml (Figure 9 ). Meanwhile, in HEK 293 cells, cotransfected with ER-ERE luciferase, RPA induced a high level of ERα and ERβ transcriptional activity as measured by luciferase production, and RPA at doses 0.01-0.1 mg/ml significantly increased ERα-ERE luciferase activity and decreased ERβ-ERE luciferase activity induced by 17β-estradiol, which demonstrated RPA; high-ERα affinity primarily showed activation effects, while low-ERβ affinity primarily showed ligand-dissociation effects.
The ER positive MCF-7 cell depends on estrogen for proliferation in monolayer culture (Darbre & Daly, 1989) . We found that RPA at any doses induced moderate proliferation of MCF7 cells but no influence on the ER negative MDA-MB-231 cell (Figure 7 ). All agonist activities of RPA in vivo and in vitro were strongly inhibited by the ER 
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